RETRACTED: The Application of Whole-Process Case Management in Patients with Triple-Negative Breast Cancer (Retracted Article)

被引:0
|
作者
Zhao, Yunyan [1 ]
Zhu, Ran [2 ]
Bai, Jie [2 ]
Li, Jie [2 ]
Jia, Xue [2 ]
Wang, Peng [2 ]
Jin, Lijun [2 ]
机构
[1] Cangzhou Cent Hosp, Dept Tumour Med Ward, Cangzhou, Peoples R China
[2] Cangzhou Cent Hosp, Dept Thyroid & Breast 3, Cangzhou, Peoples R China
关键词
EXPERIENCE;
D O I
10.1155/2022/1794288
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. To explore the application of professional whole-process case management during nursing in patients with triple-negative breast cancer. Methods. This study recruited 60 patients with triple-negative breast cancer who were diagnosed and treated at Department of Breast Surgery in our hospital assessed for eligibility between June 2018 and June 2020, and we assigned them at a ratio of 1 : 1 via the random number table method to receive either general nursing (control group) or professional whole-process case management plus general nursing (observation group). We analyzed and evaluated the hospitalization, the indwelling time of drainage tube, complications, recovery, quality of life, posttraumatic growth, and nursing satisfaction between these two groups at registration, discharge, and the sixth month after surgery, respectively. Results. Professional whole-process case management achieved a shorter duration of drainage tube placement and hospitalization and a lower incidence of postoperative complications versus general nursing (P < 0.05). Moreover, the observation group had got better recovery (P < 0.05) and a better quality of life at discharge and 6 months after surgery (P < 0.05). Professional whole-process case management obtained higher scores of posttraumatic growth and higher nursing satisfaction versus general nursing (P < 0.05). Conclusion. Whole-process case management promotes the postoperative recovery of patients with triple-negative breast cancer and shortens the duration of drainage tube indwelling and hospitalization, which lowers the incidence of postoperative complications, improves their quality of life, and enhances nursing satisfaction.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] RETRACTED: Inhibition of PKM2 sensitizes triple-negative breast cancer cells to doxorubicin (Retracted Article)
    Wang, Feng
    Yang, Yong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 454 (03) : 465 - 470
  • [2] RETRACTED: Efficacy, Safety, and Tumor Marker Inhibition of Apatinib Combined with Conventional Chemotherapy Regimens for Patients with Advanced Triple-Negative Breast Cancer (Retracted Article)
    Chen, Jianzhao
    Feng, Lixia
    Sheng, Qinghua
    Li, Lianna
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [3] RETRACTED: Expression of PD-L1 and BRCA1 in Triple-Negative Breast Cancer Patients and Relationship with Clinicopathological Characteristics (Retracted Article)
    Huang, Xianghua
    Wang, Xiangqian
    Qian, Hongyan
    Jin, Xiaoxia
    Jiang, Guoqin
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [4] RETRACTED ARTICLE: Enhancement of doxorubicin efficacy through suppression of serine synthesis in triple-negative breast cancer
    Feng Wang
    Yong Yang
    Breast Cancer Research and Treatment, 2015, 151 : 477 - 477
  • [5] RETRACTED: Effective Targeting of Triple-Negative Breast Cancer Cells by PF-4942847, a Novel Oral Inhibitor of Hsp 90 (Retracted Article)
    Mehta, Pramod P.
    Whalen, Pamela
    Baxi, Sangita M.
    Kung, Pei-Pei
    Yamazaki, Shinji
    Yin, Min-Jean
    CLINICAL CANCER RESEARCH, 2011, 17 (16) : 5432 - 5442
  • [6] RETRACTED: Long noncoding RNA LINC00511 promotes cell growth and invasion in triple-negative breast cancer by interacting with Snail (Retracted Article)
    Liu, Ruilei
    Wang, Liang
    Gan, Tianyu
    Pan, Tao
    Hang, Jianglong
    Bai, Mingjun
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 5691 - 5699
  • [7] RETRACTED: A new synthetic derivative of cryptotanshinone KYZ3 as STAT3 inhibitor for triple-negative breast cancer therapy (Retracted Article)
    Zhang, Wenda
    Yu, Wenying
    Cai, Guiping
    Zhu, Jiawen
    Zhang, Chao
    Li, Shanshan
    Guo, Jianpeng
    Yin, Guoping
    Chen, Chen
    Kong, Lingyi
    CELL DEATH & DISEASE, 2018, 9
  • [8] RETRACTED: Inhibition of Notch1 reverses EMT and chemoresistance to cisplatin via direct downregulation of MCAM in triple-negative breast cancer cells (Retracted Article)
    Zeng, De
    Liang, Yuan-Ke
    Xiao, Ying-Sheng
    Wei, Xiao-Long
    Lin, Hao-Yu
    Wu, Yang
    Bai, Jing-Wen
    Chen, Min
    Zhang, Guo-Jun
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (02) : 490 - 504
  • [9] RETRACTED: LncRNA AWPPH promotes the growth of triple-negative breast cancer by up-regulating frizzled homolog 7 (FZD7) (Retracted Article)
    Wang, Kainan
    Li, Xuelu
    Song, Chen
    Li, Man
    BIOSCIENCE REPORTS, 2018, 38
  • [10] Biology and Management of Patients With Triple-Negative Breast Cancer
    Sharma, Priyanka
    ONCOLOGIST, 2016, 21 (09): : 1050 - 1062